Yihan Li is the Director of Oncology Biostatistics at Gilead Sciences, leveraging over a decade of experience from progressive roles at AbbVie. A Ph. D. graduate from Penn State University, she specializes in applying advanced statistical methods to genomic data and clinical trials within the pharmaceutical sector.
She is a recipient of the GlaxoSmithKline Scholar Award and her doctoral research focused on meta-analysis and multiple testing methods for genomic data.
Yihan Li
Director, Oncology Biostatistics at Gilead Sciences
Raleigh-Durham-Chapel Hill Area, United States
Overview
Topics They Care About
Oncology Biostatistics
Currently leads the oncology biostatistics division at Gilead Sciences, applying her expertise to cancer research and drug development.
Clinical Trial Design
Authored multiple publications on statistical strategies in clinical trials, including multiplicity adjustments and analyzing longitudinal data.
Genomic Data Analysis
Her Ph. D. thesis and subsequent publications focused on creating novel statistical frameworks for analyzing complex genomic and gene expression data.
Media Appearances
Yihan has no verified media appearances
Work History
4-2024
Director, Oncology Biostatistics at Gilead Sciences
12-2021 - 4-2024
Director, Statistics at AbbVie
9-2020 - 11-2021
Associate Director, Statistics at AbbVie
11-2018 - 9-2020
Senior Manager, Statistics at AbbVie
6-2016 - 10-2018
Manager, Statistics at AbbVie
5-2014 - 5-2016
Senior Research Statistician at AbbVie
6-2013 - 8-2013
Clinical Statistics Intern at AbbVie
5-2012 - 8-2012
Biostatistics Intern at Janssen, Pharmaceutical Companies of Johnson & Johnson
Education
2009 - 2014
Doctor of Philosophy (Ph.D.) from Penn State University
2005 - 2009
B.S. from Peking University
More Information
Social Presence :
Prographics :
Exp : 11
Location : Raleigh-Durham-Chapel Hill Area, United States
Job Level : Mid-senior
Designation : Director, Oncology Biostatistics at Gilead Sciences
